Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients
Clinical trial NCT00627146 · COMPLETED
Trial details
- NCT number
- NCT00627146
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Primary completion
- 2007-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.